secwatch.observer — SEC 8-K summary
======================================

Issuer:     RELMADA THERAPEUTICS, INC. (RLMD)
CIK:        0001553643
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001213900-25-042024
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Relmada Therapeutics dismisses Marcum, appoints CBIZ CPAs as auditor after CBIZ acquisition of Marcum's attest business
--------------------------------------------------------------------------------

- Marcum dismissed as independent auditor on May 8, 2025, following CBIZ CPAs' Nov 1, 2024 acquisition of Marcum's attest business.
- CBIZ CPAs engaged as new auditor for fiscal year ending Dec 31, 2025; audit committee approved both actions.
- Marcum's reports for 2024 and 2023 contained an explanatory paragraph about substantial doubt as a going concern.
- No disagreements or reportable events occurred between Relmada and Marcum during the relevant periods.
- Marcum furnished a letter to the SEC agreeing with the disclosures in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1553643/000121390025042024/0001213900-25-042024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1553643/000121390025042024/ea024173301-8k_relmada.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-042024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer